NCT03645928 2025-06-19
Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors
Iovance Biotherapeutics, Inc.
Phase 2 Recruiting
Iovance Biotherapeutics, Inc.
Memorial Sloan Kettering Cancer Center
Fudan University
Vanderbilt-Ingram Cancer Center